Mr. Chair, in terms of exports, I'm going to refer to paragraph 2.60 in our audit on controlling exports. In there, we say that the agency had in fact identified illegal drugs as a high-risk area. In fact, during the period of time that was under audit, the agency had in fact made several drug seizures. I'm talking, again, about exports. They were acting on that type of intelligence that they were getting, even on exports, to try to identify if there were illegal drugs being exported. Also, the reason that looking for illegal drugs at export is important is that it's one way of helping to combat organized crime.
What the agency had identified was that they had limits on their authority to examine the non-reported packages, and that reduced their effectiveness in preventing the export of illegal drugs. Because of that, they didn't actually set illegal drugs as one of their examination priorities. What was happening was that they were acting on whatever intelligence they had, whatever suspicions they had, to try to identify whether illegal drugs were being exported. However, they didn't have all of the authority they needed to perhaps have an overall systematic approach to whether illegal drugs were being exported.
Certainly if the bill does give them the authority they need to do those random inspections of all exports, then they should be able to adjust their approach to illegal drugs.